© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
July 23rd 2021
Neal Shore, MD, discusses the complexity of prostrate cancer and factors to consider when determining management strategies.
A discussion of phenotypic and genotypic biomarkers found in prostate cancer and their implications.
July 28th 2021
An overview of the diagnostic and therapeutic applications of PSMA in prostate cancer is presented.
July 30th 2021
Dr Neal Shore explains the clinical implications of PSMA PET scans in advanced prostate cancer.
August 6th 2021
Results of the phase 3 VISION study of 177Lu-PSMA PET in advanced prostate cancer are described.
Highlights of potential future applications of PSMA ligand–directed therapies in prostate cancer.